Dyne Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
FARWELL WILDON officer: Chief Medical Officer
 Common Stock 640 $8.73 $5,587
Sale
SCALZO RICHARD WILLIAM officer: Vice President of Acco..
 Common Stock 308 $8.73 $2,689
Sale
MCNEILL JONATHAN officer: Senior Vice President ..
 Common Stock 481 $8.73 $4,199
Sale
BRUMM JOSHUA T director, officer: Chief Execut..
 Common Stock 3,384 $8.73 $29,542
Sale
FARWELL WILDON officer: Chief Medical Officer
 Common Stock 5,617 $8.56 $48,082
Sale
HIGH SUSANNA GATTI officer: Chief Operating Officer
 Common Stock 2,451 $17.22 $42,206
Sale
BESKROVNAYA OXANA officer: Chief Scientific Officer
 Common Stock 827 $16.11 $13,323
Sale
BRUMM JOSHUA T director, officer: See Remarks
 Common Stock 4,584 $16.11 $73,848
Sale
MCNEILL JONATHAN officer: See Remarks
 Common Stock 729 $16.11 $11,744
Sale
SCALZO RICHARD WILLIAM officer: See Remarks
 Common Stock 492 $16.11 $7,926
Sale
MCNEILL JONATHAN officer: See Remarks
 Common Stock 545 $15.61 $8,507
Sale
BRUMM JOSHUA T director, officer: See Remarks
 Common Stock 3,425 $15.61 $53,464
Sale
SCALZO RICHARD WILLIAM officer: See Remarks
 Common Stock 367 $15.61 $5,729
Sale
BESKROVNAYA OXANA officer: Chief Scientific Officer
 Common Stock 617 $15.61 $9,631
Purchase
LOGOS GLOBAL MANAGEMENT LP 10 percent owner
 Common Stock 700,000 N/A N/A
Purchase
VV MANAGER II, LLC 10 percent owner
 Common Stock 815,000 N/A N/A
Purchase
VV MANAGER II, LLC 10 percent owner
 Common Stock 815,000 N/A N/A
Purchase
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 660,000 N/A N/A
Purchase
KERSTEN DIRK director, 10 percent owner
 Series B Preferred Stock 5,336,179 N/A N/A
Purchase
STEHMAN-BREEN CATHERINE director
 Series B Preferred Stock 35,574 N/A N/A
Purchase
KLEIN LAWRENCE OTTO director
 Series B Preferred Stock 35,574 N/A N/A
Purchase
LUBNER DAVID CHARLES director
 Series B Preferred Stock 177,872 N/A N/A
Purchase
HURWITZ EDWARD director, 10 percent owner
 Series B Preferred Stock 1,422,981 N/A N/A
Purchase
HURWITZ EDWARD director, 10 percent owner
 Series A Preferred Stock 5,250,000 $0.33 $1,748,250
Purchase
KERSTEN DIRK director, 10 percent owner
 Series A Preferred Stock 5,250,000 $1 $5,250,000

Showing 300 to 325 of 325 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: